Health
Clinical efficacy and safety of neratinib for breast cancer | DDDT – Dove Medical Press
Clinical efficacy & safety of neratinib for the treatment of adult patients with advanced or metastatic HER2 positive breast…
Introduction
Breast cancer is the most common malignancy in women (approximately 30% of total), where it represents the first cause of cancer-related death.1
From a biological point of view, breast cancer can be classified into molecularly defined subtypes,…
Continue Reading
-
General12 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
Noosa News19 hours agoPerth Royal Show vendors upset by price hikes, say crowds are down in 2025
-
Noosa News24 hours agoResilience features in Sunshine Coast Open House
-
Business20 hours agoBell Potter names the best ASX shares to buy in October